Clinical Trial Update: Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial results validate an insulin protocol for managing glucocorticoid-induced hyperglycemia in patients with lymphoma and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Lymphoma
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lymphoma, Diabetes Mellitus, Type 2 | EARLY_Phase 1 | Status: COMPLETED